Intravitreal ranibizumab in the treatment of cystoid macular edema associated with retinitis pigmentosa

Journal of Ocular Pharmacology and Therapeutics

Volumn 25, Issue 6, 2009, Pages 545-550

  Artunay, Ozgur ^a   Yuzbasioglu, Erdal ^a   Rasier, Rifat ^a   Sengul, Alper ^a   Bahcecioglu, Halil ^a  

^a Sisli Florence Nigthingale Hastanesi Göz Bölümü   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; RANIBIZUMAB;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG RESPONSE; DRUG TREATMENT FAILURE; FEMALE; FOLLOW UP; HUMAN; MALE; OPTICAL COHERENCE TOMOGRAPHY; OUTCOME ASSESSMENT; RETINA FOVEA; RETINA MACULA CYSTOID EDEMA; RETINITIS PIGMENTOSA; SINGLE DRUG DOSE; THICKNESS; TREATMENT OUTCOME; TREATMENT REFUSAL; VISUAL ACUITY;

ACETAZOLAMIDE; ADULT; ANTIBODIES, MONOCLONAL; CARBONIC ANHYDRASE INHIBITORS; FEMALE; FOLLOW-UP STUDIES; FOVEA CENTRALIS; HUMANS; INJECTIONS, INTRAOCULAR; MACULAR EDEMA; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RETINITIS PIGMENTOSA; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 77149127360     PISSN: 10807683     EISSN: None     Source Type: Journal    
DOI: 10.1089/jop.2009.0089     Document Type: Article

References (30)

1. Baumgartner, W.A. Etiology, pathogenesis, and experimental treatment of retinitis pigmentosa. Med. Hypotheses. 54:814-824, 2000.
2. Van Soest, S., Westerveld, A., de Jong, P.T., et al. Retinitis pigmentosa: defined from a molecular point of view. Surv. Ophthalmol. 43:321-334, 1999.
3. Hamel, C. Retinitis pigmentosa. Orphanet. J. Rare Dis. 101:687-693, 2006.
4. Adler, R. Mechanisms of photoreceptor death in retinal degeneration: from the cell biology of the 1990s to the ophthalmology of the 21st century. Arch Ophthalmol. 141:79-83, 1996.
5. Bird, A.C. Investigation of disease mechanisms in retinitis pigmentosa. Ophthalmic Paediatr. Genet. 13:57-66, 1992.
6. Chong, V., and Bird, A.C. Management of inherited outer retinal dystrophies: present and future. Br. J. Ophthalmol. 83:120-122, 1999.
7. Ozdemir, H., Karacorlu, M., and Karacorlu, S. Intravitreal triamcinolone acetonide for treatment of cystoid macular oedema in patients with retinitis pigmentosa. Acta Ophthalmol. Scand. 83:248-251, 2005. (Pubitemid 40561839)
8. Hajali, M., Fishman, G.A., and Anderson, R.J. The prevalence of cystoid macular oedema in retinitis pigmentosa patients determined by optical coherence tomography. Br. J. Ophthalmol. 92:1065-1068, 2008.
9. Hirakawa, H., Iijima, H., Gohdo, T., et al. Optical coherence tomography of cystoid macular edema associated with retinitis pigmentosa. Am. J. Ophthalmol. 128:185-191, 1999.
10. Sandberg, M.A., Brockhurst, R.J., Gaudio, A.R., et al. The association between visual acuity and central retinal thickness in retinitis pigmentosa. Invest. Ophthalmol. Vis. Sci. 46:3349-3354, 2005.
11. Grover, S., Apuskin, M.A., and Fishman, G.A. Topical dorsolamide for the treatment of cystoid macular edema in patients with retinitis pigmentosa. Am. J. Ophthalmol. 141:850-858, 2006.
12. Fishman, G.A., Gilberd, L.D., Fiscella, R.G., et al. Acetazolamide for treatment of chronic macular edema in retinitis pigmentosa. Arch Ophthalmol. 107:1445-1452, 1989.
13. Cox, S.N., Hay, E., Bird, A.C. Treatment of chronic macular edema with acetazolamide. Arch Ophthalmol. 106:1190-1195, 1988.
14. Newsome, D.A., and Blackharski, P.A. Grid photocoagulation for macular edema in patients with retinitis pigmentosa. Am. J. Ophthalmol. 103:161-166, 1987.
15. Saraiva, V.S., Sallum, J.M., and Farah, M.E. Treatment of cystoid macular edema related to retinitis pigmentosa with intravitreal triamcinolone acetonide. Ophthalmic Surg. Lasers Imaging. 34:398-400, 2003.
16. Ferrara, N. Vascular endothelial growth factor: basic science and clinical progress. Endocr. Rev. 25:581-611, 2004. (Pubitemid 39099316)
17. Itturalde, D., Spaide, R.F., Meyerle, C.B., et al. Intravitreal bevacizumab (Avastin) treatment of macular edema in central retinal vein occlusion: a short term study. Retina. 26:279-284, 2006.
18. Pedersen, R., Soliman, W., Lund-Anderson, H., et al. Treatment of choroidal neovascularization using intravitreal bevacizumab. Acta Ophthalmol. Scand. 85:526-533, 2007.
19. Melo, G.B., Farah, M.E., and Aggio, F.B. Intravitreal injection of bevacizumab for cystoid macular edema in retinitis pigmentosa. Acta Ophthalmol. Scand. 85:461-463, 2007.
20. Pieramici, D.J., Rabena, M., Castellarin, A.A., et al. Ranibizumab for the treatment of macular edema associated with perfused central retinal vein occlusions. Ophthalmology. 115:47-54, 2008.
21. Vinores, S.A., Derevjanik, N.L., Ozaki, H., et al. Cellular mechanism of blood-retinal barrier dysfunction in macular edema. Doc. Ophthalmol. 97:217-228, 1999.
22. Jonas, J.B., Akkoyun, I., Kamppeter, B., et al. Branch retinal vein occlusion treated by intravitreal triamcinolone acetonide. Eye. 19:65-71, 2005. (Pubitemid 40192642)
23. Batioglu, F., Ozmert, E., Parmak, N., et al. Two-years results of intravitreal triamcinolone acetonide injection for the treatment of diabetic macular edema. Int. Ophthalmol. 27:299-306, 2007.
24. Deissler, H., Deissler, H., Lang, S., et al. Vegf-induced effects on proliferation, migration and tight junctions are restored by ranibizumab (lucentis) in microvascular retinal endothelial cells. Br. J. Ophthalmol. 92:839-843, 2008.
25. Barki, S.J., Snyher, M.R., Reid, J.M., et al. Pharmacokinetics of intravitreal bevacizumab (Avastin). Ophthalmology. 114:855-859, 2007.
26. Yuzbasioglu, E., Artunay, O., Rasier, R., et al. Intravitreal bevacizumab (Avastin) injection in retinitis pigmentosa. Curr. Eye Res. 34:231-237, 2009.
27. Nguyen, Q.D., Tatlipinar, S., Shah, S.M., et al. Vascular endothelial growth factor is a critical stimulus for diabetic macular edema. Am. J. Ophthalmol. 142:961-969, 2006.
28. Chun, D.W., Heier, J.S., Topping, T.M., et al. A pilot study of multiple intravitreal injections of ranibizumab in patients with center-involving clinically significant diabetic macular edema. Ophthalmology. 113:1706-1712, 2006.
29. Querques, G., Prascina, F., Laculli, C., et al. Intravitreal pegaptanib sodium (Macugen) for refractory cystoid macular edema in pericentral retinitis pigmentosa. Int. Ophthalmol. 29:103-107, 2009.
30. Heckenlively, J.R., Jordan, B.L., and Aptsiauri, N. Association of antiretinal antibodies and cystoid macular edema in patients with retinitis pigmentosa. Am. J. Ophthalmol. 127:565-573, 1999.